Just as the younger age and lower comorbidity burden likely explain the more pronounced reduction in all-cause mortality observed among younger individuals, these same factors may also account for their significantly lower risk of the composite outcomecomprising acute and chronic pancreatitiscompared with older participants, who instead exhibited an increased risk
Clinical guidelines exist because the safety and efficacy of tirzepatide have only been proven when used as directed by the manufacturer and the FDA
Many also report a noticeable transformation in their weight and overall well-being during this phase
For best results, experts recommend at least 150 minutes of moderate activity per week
doi: 10.1038/s41574-023-00855-y 7 WangKMaoWZhangXZhaoYFanKPanDet al
Actualmente estos medicamentos se manejan para la obesidad y para las personas que tienen sobrepeso con alguna otra enfermedad de base como hipertensin, diabetes y colesterol alto, segn la Administracin de Alimentos y Medicamentos (FDA, por sus siglas en ingls)
